{"id":17453,"date":"2011-06-26T07:15:57","date_gmt":"2011-06-26T11:15:57","guid":{"rendered":"http:\/\/asweetlife.org\/?p=17453"},"modified":"2015-12-28T07:36:24","modified_gmt":"2015-12-28T12:36:24","slug":"adding-byetta-to-diabetes-treatment-may-reduce-risk-of-heart-failure","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=17453","title":{"rendered":"Adding Byetta to Diabetes Treatment May Reduce Risk Of Heart Failure"},"content":{"rendered":"<p style=\"text-align: justify;\"><a href=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/06\/Amylin-Lilly-Logo2-1.png\" rel=\"mfp\"><img decoding=\"async\" class=\"alignleft size-full wp-image-17455 lazyload\" title=\"Amylin Lilly Logo\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/06\/Amylin-Lilly-Logo2-1.png\" alt=\"\" width=\"150\" height=\"44\" \/><\/a>Results from a retrospective analysis of more than 778,000 patients showed the addition of Byetta (exenatide) injection to pre-existing diabetes treatment regimens was associated with a reduced likelihood of heart failure, especially among patients receiving insulin. These findings were presented by Amylin and Eli Lilly in a poster session at the 71st Scientific Sessions of the American Diabetes Association in San Diego on June 25.<\/p>\n<p style=\"text-align: justify;\">The retrospective analysis used data from the GE Healthcare Centricity electronic medical record to analyze the likelihood of heart failure for Byetta in combination with certain other diabetes treatments compared with control groups of patients not treated with Byetta. Across all therapies, patients who received Byetta were 54 percent less likely to experience heart failure compared to patients not treated with Byetta.<\/p>\n<p style=\"text-align: justify;\">In addition to retrospective analyses the EXSCEL (EXenatide Study of Cardiovascular Event Lowering) study is underway and is designed to determine if there are favorable cardiovascular effects of exenatide treatment, using Bydureon (exenatide extended-release for injectable suspension), compared to standard of care with traditional diabetes medications. The study began in 2010 and will include approximately 9,500 patients, with results expected as early as 2016. BYDUREON is the proposed brand name for an investigational, once-weekly formulation of exenatide, the active ingredient in Byetta.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Results from a retrospective analysis of more than 778,000 patients showed the addition of Byetta (exenatide) injection to pre-existing diabetes treatment regimens was associated with a reduced likelihood of heart failure, especially among patients receiving insulin. These findings were presented by Amylin and Eli Lilly&#8230;<\/p>\n","protected":false},"author":131,"featured_media":29385,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1443],"tags":[277],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.9 (Yoast SEO v22.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Adding Byetta to Diabetes Treatment May Reduce Heart Failure Risk<\/title>\n<meta name=\"description\" content=\"Study results show the addition of Byetta (exenatide) to pre-existing diabetes treatment was associated with a reduced likelihood of heart failure, especially among patients receiving insulin.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=17453\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ASweetLife Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=17453\",\"url\":\"https:\/\/asweetlife.org\/?p=17453\",\"name\":\"Adding Byetta to Diabetes Treatment May Reduce Heart Failure Risk\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=17453#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=17453#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/06\/Amylin-Lilly-Logo.jpg\",\"datePublished\":\"2011-06-26T11:15:57+00:00\",\"dateModified\":\"2015-12-28T12:36:24+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\"},\"description\":\"Study results show the addition of Byetta (exenatide) to pre-existing diabetes treatment was associated with a reduced likelihood of heart failure, especially among patients receiving insulin.\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=17453#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=17453\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=17453#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/06\/Amylin-Lilly-Logo.jpg\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/06\/Amylin-Lilly-Logo.jpg\",\"width\":185,\"height\":139,\"caption\":\"Amylin Lilly Logo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=17453#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adding Byetta to Diabetes Treatment May Reduce Risk Of Heart Failure\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\",\"name\":\"ASweetLife Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"caption\":\"ASweetLife Team\"},\"url\":\"https:\/\/asweetlife.org\/?author=131\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Adding Byetta to Diabetes Treatment May Reduce Heart Failure Risk","description":"Study results show the addition of Byetta (exenatide) to pre-existing diabetes treatment was associated with a reduced likelihood of heart failure, especially among patients receiving insulin.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=17453","twitter_misc":{"Written by":"ASweetLife Team","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=17453","url":"https:\/\/asweetlife.org\/?p=17453","name":"Adding Byetta to Diabetes Treatment May Reduce Heart Failure Risk","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=17453#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=17453#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/06\/Amylin-Lilly-Logo.jpg","datePublished":"2011-06-26T11:15:57+00:00","dateModified":"2015-12-28T12:36:24+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585"},"description":"Study results show the addition of Byetta (exenatide) to pre-existing diabetes treatment was associated with a reduced likelihood of heart failure, especially among patients receiving insulin.","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=17453#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=17453"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=17453#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/06\/Amylin-Lilly-Logo.jpg","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/06\/Amylin-Lilly-Logo.jpg","width":185,"height":139,"caption":"Amylin Lilly Logo"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=17453#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"Adding Byetta to Diabetes Treatment May Reduce Risk Of Heart Failure"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585","name":"ASweetLife Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","caption":"ASweetLife Team"},"url":"https:\/\/asweetlife.org\/?author=131"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/17453"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17453"}],"version-history":[{"count":0,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/17453\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/29385"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}